CTRI/2024/07/070465尚未招募2 期
Therapeutic efficacy of ultra-low dose rituximab in pemphigus vulgaris: a pilot study - NI
AIIMS, New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Adult patients with pemphigus vulgaris
排除标准
- •1. Patients who have received rituximab in the last
- •2. Patients with known absolute contra-indications
- •to corticosteroids or rituximab
- •3. Pregnant and lactating females
研究者
相似试验
未知
2 期
Clinical study for effectiveness of rituximab for acquired coagulopathyacquired coagulopathyJPRN-UMIN000024612Gunma University10
已完成
不适用
A study of the efficacy and safety to rituximab in treating adult onset refractory nephrotic syndromeRefractory nephrotic syndromeJPRN-UMIN000021143Fujita Health University School of Medicine, Department of Nephrology10
招募中
不适用
Efficacy and safety of rituximab for intractable immunogenic neurological disorder in childreJPRN-UMIN000009421Department of Pediatrics, Kobe Universtiy Graduate School of Medicine10
进行中（未招募）
1 期
Efficacy and safety of rituximab in the treatment of good prognosis microscopic polyangiitisEUCTR2018-000637-12-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)106
招募中
2 期
A pilot study of combining rituximab and low-dose (1.0Gy) total nodal irradiation in treatment of extensive chronic graft-versus-host diseaseChronic graft-versus-host disease (GVHD)Blood - Haematological diseasesACTRN12607000628448Simon He and Andrew Grigg20